Brown Advisory’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-389,122
Closed -$2.74M 1435
2025
Q4
$2.74M Sell
389,122
-2,997,842
-89% -$18.1M ﹤0.01% 622
2025
Q3
$18.6M Sell
3,386,964
-1,823,674
-35% -$8.94M 0.02% 338
2025
Q2
$26.9M Sell
5,210,638
-611,977
-11% -$3.67M 0.04% 273
2025
Q1
$38.8M Sell
5,822,615
-192,227
-3% -$1.46M 0.06% 215
2024
Q4
$44.3M Sell
6,014,842
-368,357
-6% -$2.64M 0.06% 229
2024
Q3
$44.7M Sell
6,383,199
-134,146
-2% -$806K 0.06% 231
2024
Q2
$32M Sell
6,517,345
-44,382
-0.7% -$268K 0.04% 267
2024
Q1
$40.5M Buy
6,561,727
+1,402,747
+27% +$9.45M 0.05% 248
2023
Q4
$40.4M Buy
5,158,980
+1,062,887
+26% +$6.85M 0.06% 233
2023
Q3
$28.1M Buy
+4,096,093
New +$33.2M 0.05% 263
2021
Q4
Sell
-2,093,570
Closed -$30.4M 1265
2021
Q3
$30.4M Buy
2,093,570
+725
+0% +$14K 0.04% 250
2021
Q2
$58.3M Buy
+2,092,845
New +$55.3M 0.09% 174

Other funds holding LFST

Brown Advisory's LFST Position: Q1 2026 in Review

Brown Advisory sold out of Lifestance Health (LFST) in Q1 2026, closing a stake of 389,122 shares — an estimated $2.74M sold.

Brown Advisory first reported a position in LFST in Q2 2021 and held it in 12 quarters. The position peaked at $58.3M in Q2 2021. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Brown Advisory reported no remaining Lifestance Health position as of Q1 2026 after selling out during the quarter.
  • Brown Advisory sold 389,122 Lifestance Health shares in Q1 2026, an estimated $2.74M.
  • Brown Advisory first reported a position in Lifestance Health in Q2 2021 and held it in 12 quarters.
  • Brown Advisory's Lifestance Health position peaked at $58.3M in Q2 2021.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.